Download Sample
Author
Muni Kumar Meravath is a seasoned Healthcare Market Research Analyst with over 6 years of experience in the healthc.....
Europe Hemostasis Diagnostics Market: By Product Type, By Test Type, By Technology, By End-User ), and Country
Europe Hemostasis Diagnostics Market: By Product Type, By Test Type, By Technology, By End-User ), and Country
Europe Hemostasis Diagnostics Market size values US$ XX billion in 2023 and poised to grow at a CAGR of X% from 2024-2030. Hemostasis diagnostics are the devices used to determine the hemostatic defects, which cause excessive bleeding. Hemostasis is defined as the stopping or slowing the blood flow from damaged blood vessel. During the hemostasis, blood changes from liquid state to the gelatinous state. Hemostasis maintained in the body by three mechanisms namely, blood coagulation, platelet plug formation, and vasoconstriction. Hemostasis diagnostics may help to predict the cause of bleeding during surgery by identifying the hemostatic defects in patients. Different types of tests such as prothrombin test, activated clotting time, platelet function, and other coagulation tests are carried to identify the hemostasis defects. Increase in the prevalence of hemostasis related disease in Europe countries (according to The European National Registry of Congenital Coagulopathies 2017, the number of cases identified with hemostasis is increased from 7000 in 2000 to 11,000 in 2015), rise in number of surgery cases, rise in R&D investment for novel tests and devices innovation, and well developed healthcare infrastructure are expected to boost the hemostasis diagnostics market. However, high cost of advanced hemostasis products, and stringent regulations for the test approvals are expected to hamper the growth of hemostasis diagnostics market. This market research report considers the influence of COVID-19 on the market and includes insights, analysis, projections, and predictions.
Increase in the incidence of blood clotting disorders such as haemophilia (according to National Hemophilia Foundation, approximately 400,000 incidences of haemophilia is observed in 2012), growing number of trauma patients and surgeries, and the introduction of biodegradable and cost-effective products are expected to propel the market growth over the forecast period. Moreover, technological advancements in the hemostasis diagnostics such as accurate results in less time, increase in awareness about the hemostasis diagnostics, and rise in R&D investment for novel tests and devices boost the market. However, the high cost of advanced hemostasis products and stringent regulations for the test approvals are expected to hamper the growth of market over the forecast period.
Europe hemostasis diagnosis market is segmented into U.K., France, Germany, Russia, Spain, Italy, Poland, and Rest of Europe. U.K. hemostasis diagnostics market accounted for significant share, which is attributed to rise in prevalence of hemophilia (according to World Federation of Hemophilia Global Survey 2010, approximately 6,573 people are suffering from hemophilia), increase in prevalence of cardiovascular diseases, and adoption of newer technologies are expected to propel the market in U.K. France hemostasis diagnostics market is growing due to rise in funding for launching test kits. For instance, in March 2016, Emosis, a French company raised 1 Mn Euros funding from Cap Innov for the development of hemostasis test kits. Germany hemostasis market growth driven by increase in the R&D for innovation of newer products, rise in prevalence of hemophilia disease, and expansion of business by market players in the country. Russia hemostasis diagnostics market is rising due to organization of training programs for doctors on coagulation testing by market players.
Latin America
Europe
Asia Pacific
Middle East
North America
|
Report Benchmarks |
Details |
|
By Product Type |
|
|
By Test Type |
|
|
By Technology |
|
|
By End User |
|
Download Free Sample Report
2023 is the base year and 2030 is the forecast year.
The report covers the countries market data: Germany, France, Italy, Spain, and United Kingdom (UK)
Hoffmann-La Roche Ltd., Sysmex Corporation, Abbott Laboratories, Alere Inc., Nihon Kohden Corporation
| 1.Executive Summary |
| 2. Europe Hemostasis Diagnostics Market Introduction |
| 2.1. Europe Hemostasis Diagnostics Market - Taxonomy |
| 2.2. Europe Hemostasis Diagnostics Market - Definitions |
| 2.2.1. By Product Type |
| 2.2.2. By Test Type |
| 2.2.3. By Technology |
| 2.2.4. By End User |
| 2.2.5. By Country |
| 3. Europe Hemostasis Diagnostics Market Dynamics |
| 3.1. Drivers |
| 3.2. Restraints |
| 3.3. Opportunities/Unmet Needs of the Market |
| 3.4. Trends |
| 3.5. Product Landscape |
| 3.6. New Product Launches |
| 3.7. Impact of COVID 19 on Market |
| 4. Europe Hemostasis Diagnostics Market Analysis, 2020 - 2024 and Forecast 2025 - 2031 |
| 4.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) |
| 4.3. Market Opportunity Analysis |
| 5. Europe Hemostasis Diagnostics Market By Product Type , 2020 - 2024 and Forecast 2025 - 2031 (Sales Value USD Million) |
| 5.1. Systems, |
| 5.1.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 5.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.1.3. Market Opportunity Analysis |
| 5.2. Consumables, |
| 5.2.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 5.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.2.3. Market Opportunity Analysis |
| 5.3. Point-of-Care Testing Devices |
| 5.3.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 5.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.3.3. Market Opportunity Analysis |
| 6. Europe Hemostasis Diagnostics Market By Test Type, 2020 - 2024 and Forecast 2025 - 2031 (Sales Value USD Million) |
| 6.1. Fibrinogen Test, |
| 6.1.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 6.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.1.3. Market Opportunity Analysis |
| 6.2. Activated Clotting Time, |
| 6.2.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 6.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.2.3. Market Opportunity Analysis |
| 6.3. Platelet Function, |
| 6.3.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 6.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.3.3. Market Opportunity Analysis |
| 6.4. Prothrombin Time, |
| 6.4.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 6.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.4.3. Market Opportunity Analysis |
| 6.5. Heparin & Protamine Dose-Response Test For ACT, |
| 6.5.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 6.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.5.3. Market Opportunity Analysis |
| 6.6. Activated Partial Thromboplastin Time, |
| 6.6.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 6.6.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.6.3. Market Opportunity Analysis |
| 6.7. Anti-Factor Xa, |
| 6.7.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 6.7.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.7.3. Market Opportunity Analysis |
| 6.8. Other Coagulation Tests |
| 6.8.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 6.8.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.8.3. Market Opportunity Analysis |
| 7. Europe Hemostasis Diagnostics Market By Technology, 2020 - 2024 and Forecast 2025 - 2031 (Sales Value USD Million) |
| 7.1. Optical, |
| 7.1.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 7.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.1.3. Market Opportunity Analysis |
| 7.2. Mechanical, |
| 7.2.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 7.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.2.3. Market Opportunity Analysis |
| 7.3. Electrochemical, |
| 7.3.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 7.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.3.3. Market Opportunity Analysis |
| 7.4. Others |
| 7.4.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 7.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.4.3. Market Opportunity Analysis |
| 8. Europe Hemostasis Diagnostics Market By End User, 2020 - 2024 and Forecast 2025 - 2031 (Sales Value USD Million) |
| 8.1. Hospitals, |
| 8.1.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 8.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.1.3. Market Opportunity Analysis |
| 8.2. Clinics, |
| 8.2.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 8.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.2.3. Market Opportunity Analysis |
| 8.3. Diagnostic Centres, |
| 8.3.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 8.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.3.3. Market Opportunity Analysis |
| 8.4. Others (POC) |
| 8.4.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 8.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.4.3. Market Opportunity Analysis |
| 9. Europe Hemostasis Diagnostics Market By Country, 2020 - 2024 and Forecast 2025 - 2031 (Sales Value USD Million) |
| 9.1. Germany |
| 9.1.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 9.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 9.1.3. Market Opportunity Analysis |
| 9.2. France |
| 9.2.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 9.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 9.2.3. Market Opportunity Analysis |
| 9.3. Italy |
| 9.3.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 9.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 9.3.3. Market Opportunity Analysis |
| 9.4. United Kingdom (UK) |
| 9.4.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 9.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 9.4.3. Market Opportunity Analysis |
| 9.5. Spain |
| 9.5.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 9.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 9.5.3. Market Opportunity Analysis |
| 10.Germany Hemostasis Diagnostics Market ,2020 - 2024 and Forecast 2025 - 2031 (Sales Value USD Million) |
| 10.1. Product Type Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.1.1.Systems, |
| 10.1.2.Consumables, |
| 10.1.3.Point-of-Care Testing Devices |
| 10.2. Test Type Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.2.1.Fibrinogen Test, |
| 10.2.2.Activated Clotting Time, |
| 10.2.3.Platelet Function, |
| 10.2.4.Prothrombin Time, |
| 10.2.5.Heparin & Protamine Dose-Response Test For ACT, |
| 10.2.6.Activated Partial Thromboplastin Time, |
| 10.2.7.Anti-Factor Xa, |
| 10.2.8.Other Coagulation Tests |
| 10.3. Technology Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.3.1.Optical, |
| 10.3.2.Mechanical, |
| 10.3.3.Electrochemical, |
| 10.3.4.Others |
| 10.4. End User Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.4.1.Hospitals, |
| 10.4.2.Clinics, |
| 10.4.3.Diagnostic Centres, |
| 10.4.4.Others (POC) |
| 11.France Hemostasis Diagnostics Market ,2020 - 2024 and Forecast 2025 - 2031 (Sales Value USD Million) |
| 11.1. Product Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.1.1.Systems, |
| 11.1.2.Consumables, |
| 11.1.3.Point-of-Care Testing Devices |
| 11.2. Test Type Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.2.1.Fibrinogen Test, |
| 11.2.2.Activated Clotting Time, |
| 11.2.3.Platelet Function, |
| 11.2.4.Prothrombin Time, |
| 11.2.5.Heparin & Protamine Dose-Response Test For ACT, |
| 11.2.6.Activated Partial Thromboplastin Time, |
| 11.2.7.Anti-Factor Xa, |
| 11.2.8.Other Coagulation Tests |
| 11.3. Technology Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.3.1.Optical, |
| 11.3.2.Mechanical, |
| 11.3.3.Electrochemical, |
| 11.3.4.Others |
| 11.4. End User Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.4.1.Hospitals, |
| 11.4.2.Clinics, |
| 11.4.3.Diagnostic Centres, |
| 11.4.4.Others (POC) |
| 12.Italy Hemostasis Diagnostics Market ,2020 - 2024 and Forecast 2025 - 2031 (Sales Value USD Million) |
| 12.1. Product Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.1.1.Systems, |
| 12.1.2.Consumables, |
| 12.1.3.Point-of-Care Testing Devices |
| 12.2. Test Type Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.2.1.Fibrinogen Test, |
| 12.2.2.Activated Clotting Time, |
| 12.2.3.Platelet Function, |
| 12.2.4.Prothrombin Time, |
| 12.2.5.Heparin & Protamine Dose-Response Test For ACT, |
| 12.2.6.Activated Partial Thromboplastin Time, |
| 12.2.7.Anti-Factor Xa, |
| 12.2.8.Other Coagulation Tests |
| 12.3. Technology Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.3.1.Optical, |
| 12.3.2.Mechanical, |
| 12.3.3.Electrochemical, |
| 12.3.4.Others |
| 12.4. End User Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.4.1.Hospitals, |
| 12.4.2.Clinics, |
| 12.4.3.Diagnostic Centres, |
| 12.4.4.Others (POC) |
| 13.United Kingdom (UK) Hemostasis Diagnostics Market ,2020 - 2024 and Forecast 2025 - 2031 (Sales Value USD Million) |
| 13.1. Product Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 13.1.1.Systems, |
| 13.1.2.Consumables, |
| 13.1.3.Point-of-Care Testing Devices |
| 13.2. Test Type Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 13.2.1.Fibrinogen Test, |
| 13.2.2.Activated Clotting Time, |
| 13.2.3.Platelet Function, |
| 13.2.4.Prothrombin Time, |
| 13.2.5.Heparin & Protamine Dose-Response Test For ACT, |
| 13.2.6.Activated Partial Thromboplastin Time, |
| 13.2.7.Anti-Factor Xa, |
| 13.2.8.Other Coagulation Tests |
| 13.3. Technology Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 13.3.1.Optical, |
| 13.3.2.Mechanical, |
| 13.3.3.Electrochemical, |
| 13.3.4.Others |
| 13.4. End User Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 13.4.1.Hospitals, |
| 13.4.2.Clinics, |
| 13.4.3.Diagnostic Centres, |
| 13.4.4.Others (POC) |
| 14.Spain Hemostasis Diagnostics Market ,2020 - 2024 and Forecast 2025 - 2031 (Sales Value USD Million) |
| 14.1. Product Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 14.1.1.Systems, |
| 14.1.2.Consumables, |
| 14.1.3.Point-of-Care Testing Devices |
| 14.2. Test Type Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 14.2.1.Fibrinogen Test, |
| 14.2.2.Activated Clotting Time, |
| 14.2.3.Platelet Function, |
| 14.2.4.Prothrombin Time, |
| 14.2.5.Heparin & Protamine Dose-Response Test For ACT, |
| 14.2.6.Activated Partial Thromboplastin Time, |
| 14.2.7.Anti-Factor Xa, |
| 14.2.8.Other Coagulation Tests |
| 14.3. Technology Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 14.3.1.Optical, |
| 14.3.2.Mechanical, |
| 14.3.3.Electrochemical, |
| 14.3.4.Others |
| 14.4. End User Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 14.4.1.Hospitals, |
| 14.4.2.Clinics, |
| 14.4.3.Diagnostic Centres, |
| 14.4.4.Others (POC) |
| 15. Competition Landscape |
| 15.1. Market Player Profiles (Introduction, Brand/Product Sales, Financial Analysis, Product Offerings, Key Developments, Collaborations, M & A, Strategies, and SWOT Analysis) |
| 15.2.1.Hoffmann-La Roche Ltd. |
| 15.2.2.Sysmex Corporation |
| 15.2.3.Abbott Laboratories |
| 15.2.4.Alere Inc. |
| 15.2.5.Nihon Kohden Corporation |
| 15.2.6.Siemens Healthineers |
| 15.2.7.Beckman Coulter, Inc. |
| 16. Research Methodology |
| 17. Appendix and Abbreviations |
Key Market Players
Author
Muni Kumar Meravath is a seasoned Healthcare Market Research Analyst with over 6 years of experience in the healthcare domain, encompassing pharmaceuticals, medical devices, and diagnostics. A graduate in Pharmacy, he possesses a strong foundation in the intricacies of the healthcare sector. He further enhanced his expertise by pursuing an MBA in Pharmaceuticals, equipping him with valuable business acumen. His analytical skills and market insights have contributed to strategic decision-making and enhanced market positioning for various healthcare organizations. Committed to driving innovation and excellence, Muni continues to seek opportunities to improve healthcare delivery through data-driven insights.